oxprenolol has been researched along with Myasthenia Gravis in 2 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weber, JC | 1 |
| Herishanu, Y | 1 |
| Rosenberg, P | 1 |
2 other studies available for oxprenolol and Myasthenia Gravis
| Article | Year |
|---|---|
Beta-adrenoreceptor antagonists and diplopia.
Topics: Angina Pectoris; Diplopia; Drug Interactions; Humans; Male; Middle Aged; Myasthenia Gravis; Oxprenol | 1982 |
Letter: beta-Blockers and myasthenia gravis.
Topics: Adrenergic beta-Antagonists; Aged; Female; Humans; Middle Aged; Myasthenia Gravis; Oxprenolol; Propr | 1975 |